Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Serfaty

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Presse Medicale (Paris, France : 1983)|November 24, 2019
[Pharmacological treatment of NASH]Lawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2009
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic dataLawrence Serfaty, Jacqueline Capeau
Presse Medicale (Paris, France : 1983)|July 5, 2011
[Nonalcoholic fatty liver disease]Maud Lemoine, Lawrence Serfaty
Gastroenterology|January 29, 2016
Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver DiseaseBachir Taouli, Lawrence Serfaty
Gut|November 14, 2007
Ursodeoxycholic acid in chronic hepatitis CRaoul Poupon, Lawrence Serfaty
Journal of Hepatology|September 28, 2011
Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesisMaud Lemoine, Lawrence Serfaty
La Revue Du Praticien|November 1, 2005
[Liver cirrhosis in adults: etiology and specific treatments]Laetitia Fartoux, Lawrence Serfaty
Gastroenterologie Clinique Et Biologique|October 11, 2007
[A metabolic approach to hepatitis C]Laetitia Fartoux, Lawrence Serfaty
Journal of Hepatology|October 16, 2012
Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?Alina Pascale, Lawrence Serfaty
Gastroenterology|July 27, 2016
Effect of Registries and Cohort Studies on HCV TreatmentNezam H Afdhal, Lawrence Serfaty
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Presse Medicale (Paris, France : 1983)|November 24, 2019
[Pharmacological treatment of NASH]Lawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2009
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic dataLawrence Serfaty, Jacqueline Capeau
Presse Medicale (Paris, France : 1983)|July 5, 2011
[Nonalcoholic fatty liver disease]Maud Lemoine, Lawrence Serfaty
Gastroenterology|January 29, 2016
Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver DiseaseBachir Taouli, Lawrence Serfaty
Gut|November 14, 2007
Ursodeoxycholic acid in chronic hepatitis CRaoul Poupon, Lawrence Serfaty
Journal of Hepatology|September 28, 2011
Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesisMaud Lemoine, Lawrence Serfaty
La Revue Du Praticien|November 1, 2005
[Liver cirrhosis in adults: etiology and specific treatments]Laetitia Fartoux, Lawrence Serfaty
Gastroenterologie Clinique Et Biologique|October 11, 2007
[A metabolic approach to hepatitis C]Laetitia Fartoux, Lawrence Serfaty
Journal of Hepatology|October 16, 2012
Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?Alina Pascale, Lawrence Serfaty
Gastroenterology|July 27, 2016
Effect of Registries and Cohort Studies on HCV TreatmentNezam H Afdhal, Lawrence Serfaty
Pageof 14